| [1] | De Martinis M, Sirufo MM, Polsinelli M, et al. Gender differences in osteoporosis: a single-center observational study. World J Mens Health, 2021; 39, 750−9. doi: 10.5534/wjmh.200099 |
| [2] | Li Y, Huang Z, Gong Y, et al. Retrospective analysis of the relationship between bone mineral density and body composition in a health check-up Chinese population. Front Endocrinol, 2022; 13, 965758. doi: 10.3389/fendo.2022.965758 |
| [3] | Odén A, McCloskey EV, Kanis JA, et al. Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int, 2015; 26, 2243−8. doi: 10.1007/s00198-015-3154-6 |
| [4] | Elbers LPB, Raterman HG, Lems WF. Bone mineral density loss and fracture risk after discontinuation of anti-osteoporotic drug treatment: a narrative review. Drugs, 2021; 81, 1645−55. doi: 10.1007/s40265-021-01587-x |
| [5] | Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb, 2005; 12, 295−300. doi: 10.5551/jat.12.295 |
| [6] | Bovolini A, Garcia J, Andrade MA, et al. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med, 2021; 42, 199−214. doi: 10.1055/a-1263-0898 |
| [7] | Bishehsari F, Voigt RM, Keshavarzian A. Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer. Nat Rev Endocrinol, 2020; 16, 731−39. doi: 10.1038/s41574-020-00427-4 |
| [8] | Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras, 2019; 65, 9−15. doi: 10.1590/1806-9282.65.1.9 |
| [9] | Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras, 2021; 67, 549−54. doi: 10.1590/1806-9282.20201005 |
| [10] | Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male, 2020; 23, 1098−102. doi: 10.1080/13685538.2019.1678126 |
| [11] | Aktas G, Alcelik A, Ozlu T, et al. Association between omentin levels and insulin resistance in pregnancy. Exp Clin Endocrinol Diabetes, 2014; 122, 163−6. doi: 10.1055/s-0034-1370917 |
| [12] | Chen YY, Kao TW, Wang CC, et al. Exploring the link between metabolic syndrome and risk of dysmobility syndrome in elderly population. PLoS One, 2018; 13, e0207608. doi: 10.1371/journal.pone.0207608 |
| [13] | Lin HH, Huang CY, Hwang LC. Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants. Arch Osteoporos, 2018; 13, 48. doi: 10.1007/s11657-018-0467-z |
| [14] | Yue C, Ding N, Xu LL, et al. Prescreening for osteoporosis with forearm bone densitometry in health examination population. BMC Musculoskelet Disord, 2022; 23, 377. doi: 10.1186/s12891-022-05325-6 |
| [15] | Anam AK, Insogna K. Update on osteoporosis screening and management. Med Clin North Am, 2021; 105, 1117−34. doi: 10.1016/j.mcna.2021.05.016 |
| [16] | Zeng Q, Li N, Wang QQ, et al. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res, 2019; 34, 1789−97. doi: 10.1002/jbmr.3757 |
| [17] | National Health and Family Planning Commission of the People’s Republic of China. China clinical smoking cessation guide line. People’s Medical Publishing House. 2015, 88-95. (In Chinese) |
| [18] | Gong Y, Zeng Q, Yan Y, et al. Association between lifestyle and gastroesophageal reflux disease questionnaire scores: a cross-sectional study of 37442 Chinese adults. Gastroenterol Res Pract, 2019; 2019, 5753813. |
| [19] | Gao J, Dong ZN, Tian YP. The clinical application research of enzymatic cycling assay for detecting serum Hcy concentration. Chin J Lab Med, 2006; 29, 199−202. (In Chinese) |
| [20] | Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the diagnosis and treatment of primary osteoporosis (2022). Chin J Endocrinol Metab, 2023; 39, 377−406. (In Chinese) |
| [21] | Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults. 2016 Chinese guideline for the management of dyslipidemia in adults. Chin J Cardiol, 2016; 44, 833−53. (In Chinese) |
| [22] | Ström O, Borgström F, Kanis JA, et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared incollaboration with the international osteoporosis foundation (IOF) and the European federation of pharmaceutical industry associations (EFPIA). Arch Osteoporos, 2011; 6, 59−155. doi: 10.1007/s11657-011-0060-1 |
| [23] | Curtis EM, Moon RJ, Harvey NC, et al. The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone, 2017; 104, 29−38. doi: 10.1016/j.bone.2017.01.024 |
| [24] | Nwogu UB, Agwu KK, Anakwue AMC, et al. Bone mineral density in an urban and a rural children population -a comparative, population-based study in Enugu State, Nigeria. Bone, 2019; 127, 44−8 doi: 10.1016/j.bone.2019.05.028 |
| [25] | Wani K, Yakout SM, Ansari MGA, et al. Metabolic syndrome in Arab adults with low bone mineral density. Nutrients, 2019; 11, 1405. doi: 10.3390/nu11061405 |
| [26] | Al-Dawood E, Zafar M. Association between metabolic syndrome and bone mineral density among menopausal Saudi women: case-control study. Med J Islam Repub Iran, 2021; 35, 26. |
| [27] | Wong SK, Chin KY, Suhaimi FH, et al. The relationship between metabolic syndrome and osteoporosis: a review. Nutrients, 2016; 8, 347. doi: 10.3390/nu8060347 |
| [28] | Chen DZ, Xu QM, Wu XX, et al. The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in Eastern China. Int J Endocrinol, 2018; 2018, 2314769. |
| [29] | Liu WD, Wang CS, Hao J, et al. Association between metabolic syndrome and osteoporosis: a systematic review and meta-analysis. Int J Endocrinol, 2021; 2021, 6691487. |
| [30] | Nielson CM, Srikanth P, Orwoll ES. Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res, 2012; 27, 1−10. doi: 10.1002/jbmr.1486 |
| [31] | Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 2009; 9, 88. doi: 10.1186/1471-2458-9-88 |
| [32] | Jiang BC, Villareal DT. Weight loss-induced reduction of bone mineral density in older adults with obesity. J Nutr Gerontol Geriatr, 2019; 38, 100−14. doi: 10.1080/21551197.2018.1564721 |
| [33] | Kammire DE, Walkup MP, Ambrosius WT, et al. Effect of weight change following intentional weight loss on bone health in older adults with obesity. Obesity, 2019; 27, 1839−45. doi: 10.1002/oby.22604 |
| [34] | Turcotte AF, O'Connor S, Morin SN, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One, 2021; 16, e0252487. doi: 10.1371/journal.pone.0252487 |
| [35] | Piñar-Gutierrez A, García-Fontana C, García-Fontana B, et al. Obesity and bone health: a complex relationship. Int J Mol Sci, 2022; 23, 8303. doi: 10.3390/ijms23158303 |
| [36] | Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 2010; 142, 309−19. doi: 10.1016/j.cell.2010.06.002 |
| [37] | Ferron M, Wei JW, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010; 142, 296−308. doi: 10.1016/j.cell.2010.06.003 |
| [38] | Zhou JJ, Zhang Q, Yuan XL, et al. Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone, 2013; 57, 30−5. doi: 10.1016/j.bone.2013.07.013 |
| [39] | Tang YC, Wang SH, Yi Q, et al. High-density lipoprotein cholesterol is negatively correlated with bone mineral density and has potential predictive value for bone loss. Lipids Health Dis, 2021; 20, 75. doi: 10.1186/s12944-021-01497-7 |
| [40] | Li GHY, Cheung CL, Au PCM, et al. Positive effects of low LDL-C and statins on bone mineral density: an integrated epidemiological observation analysis and Mendelian randomization study. Int J Epidemiol, 2020; 49, 1221−35. doi: 10.1093/ije/dyz145 |
| [41] | Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol, 2022; 123, 14−21. doi: 10.1016/j.semcdb.2021.05.014 |
| [42] | Iantomasi T, Romagnoli C, Palmini G, et al. Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci, 2023; 24, 3772. doi: 10.3390/ijms24043772 |
| [43] | Nakagami H, Morishita R. Hypertension and osteoporosis. Clin Calcium, 2013; 23, 497-503. (In Japanese |
| [44] | Sequi-Dominguez I, Alvarez-Bueno C, Martinez-Vizcaino V, et al. Effectiveness of mobile health interventions promoting physical activity and lifestyle interventions to reduce cardiovascular risk among individuals with metabolic syndrome: systematic review and meta-analysis. J Med Internet Res, 2020; 22, e17790. doi: 10.2196/17790 |
| [45] | Papadopoulou SK, Papadimitriou K, Voulgaridou G, et al. Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia: a narrative review. Nutrients, 2021; 13, 4499. doi: 10.3390/nu13124499 |